- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
958
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
958 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
TPT | UK£0.45 | 0% | -7.0% | UK£88.5m | n/a | PE167.3x | E90.2% | 8.0% | Retail | ||
MIL | AU$1.15 | 0% | 209.5% | AU$54.0m | n/a | PE22.8x | E51.8% | 0% | Commercial Services | ||
6086 | JP¥1,500.00 | -6.5% | -12.9% | JP¥14.4b | JP¥1,850.00 | PE15.9x | E8.7% | 37.1% | Commercial Services | ||
FEYTECH | RM 0.89 | -2.7% | n/a | RM 746.2m | RM 1.10 | PE17x | E20.4% | n/a | Automobiles | ||
1347 | HK$19.02 | 16.7% | -4.1% | HK$39.5b | HK$21.37 | PE47.9x | E33.2% | 0.9% | Semiconductors | ||
4551 | NT$129.50 | -2.3% | -4.8% | NT$14.9b | NT$123.86 | PE26.3x | E26.5% | 1.9% | Automobiles | ||
300445 | CN¥15.27 | 14.8% | -4.4% | CN¥3.1b | CN¥22.00 | PE27.3x | E25.3% | 0.5% | Tech | ||
EVTC | US$33.90 | 2.7% | -8.8% | US$2.1b | US$37.40 | PE31.3x | E21.4% | 0.6% | Diversified Financials | ||
688581 | CN¥55.90 | 16.0% | -32.5% | CN¥4.3b | CN¥73.00 | PE17.1x | E21.3% | 1.9% | Healthcare | ||
TAL | US$10.80 | 34.0% | 18.6% | US$6.2b | US$13.47 | PE123.7x | E32.9% | 0% | Consumer Services | ||
531761 | ₹586.20 | -2.6% | -16.9% | ₹24.2b | ₹735.17 | PE58.6x | E37.0% | 0.2% | Capital Goods | ||
PCO | zł19.82 | 13.3% | -2.1% | zł11.4b | zł29.45 | PE22.3x | E31.8% | n/a | Retail | ||
STKL | US$6.52 | -2.2% | 93.5% | US$815.7m | US$9.83 | PS1.1x | E159.6% | n/a | Food, Beverage & Tobacco | ||
EXA | €17.86 | 1.9% | 2.1% | €303.7m | €23.50 | PB2.4x | E108.0% | n/a | Capital Goods | ||
688007 | CN¥14.13 | 17.8% | -44.4% | CN¥6.5b | CN¥19.43 | PE165.6x | E60.9% | 0.5% | Tech | ||
MPTI | US$41.02 | 14.4% | 131.8% | US$107.7m | US$47.00 | PE23.6x | E20.5% | n/a | Tech | ||
MIN | AU$49.14 | 33.9% | -27.3% | AU$9.6b | AU$52.46 | PE76.7x | E38.3% | 0% | Materials | ||
VENUSPIPES | ₹2,218.80 | -0.5% | 69.4% | ₹45.2b | ₹2,637.60 | PE47x | E29.3% | 0.05% | Materials | ||
GRF | €9.85 | 0.1% | -19.9% | €6.2b | €17.72 | PE40.4x | E28.3% | n/a | Pharmaceuticals & Biotech | ||
INF | UK£8.40 | -1.2% | 12.6% | UK£11.1b | UK£9.88 | PE35.5x | E21.6% | 2.2% | Media | ||
688628 | CN¥33.90 | 22.4% | -22.4% | CN¥3.6b | n/a | PE22.5x | E25.4% | 1.8% | Tech | ||
ALNSE | €29.80 | -0.7% | 25.2% | €94.6m | €27.80 | PE22.9x | E20.2% | 0.7% | Capital Goods | ||
STAA | US$33.87 | 7.2% | -15.3% | US$1.5b | US$49.54 | PE100.3x | E39.1% | n/a | Healthcare | ||
PAHC | US$22.10 | -1.4% | 77.8% | US$893.9m | US$15.60 | PE370.5x | E51.5% | 2.2% | Pharmaceuticals & Biotech |